Literature DB >> 21155877

Severity of initial stent angulation predicts reintervention after successful palliative enteral stenting for malignant luminal obstruction.

Eric Y T Lee1, Michael J Bourke, Stephen J Williams, Ahmad Alrubaie, Vu Kwan, Adam A Bailey, Paul M Lynch, Sze M Loh.   

Abstract

BACKGROUND AND AIM: Recurrent stent obstruction necessitating reintervention is problematic and incompletely understood. The aim of the present study was to identify factor(s) predisposing to reintervention.
METHODS: Retrospective review of patients (n = 117) referred to a single major endoscopic referral centre for palliative enteral stenting from 1999 to 2006. Twelve were excluded due to inadequate follow-up data (n = 7) or initial radiographic documentation (n = 5). A total of 105 patients (gastroduodenal n = 57, colonic n = 48) were therefore analyzed. The primary outcome of interest was recurrent obstruction necessitating reintervention. Kaplan-Meier analysis of potential factors predisposing to reintervention, including stent angulation (mild [<15°], moderate [15°-90°], severe [>90°]) was completed for 98 patients (technically successful enteral stenting).
RESULTS: Technical and clinical success were achieved in 98 of 105 (93.3%) and 92 of 98 (93.9%) cases, respectively. Post-stenting median survival was 97.5 days (range 3-1054). Eighteen patients (18.4%) required reintervention for stent obstruction at a median time to reintervention of 85 days (range 7-481). Increased stent angulation (severe vs mild hazard ratio 6.73 (95% confidence interval 1.59-27.59), P = 0.009) was the only statistically significant factor in multivariate analysis predicting reintervention.
CONCLUSIONS: Despite its limitation as a retrospective review, this study found that reintervention for stent obstruction is necessary in almost one in five cases, and increasing severity of stent angulation is the most important risk factor.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21155877     DOI: 10.1111/j.1440-1746.2010.06523.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  The Great View Forward: The Use of a Colonoscope for Distal Duodenal Stent Placement.

Authors:  A Minervini; A Lauro; N Pagano; S Vaccari; V D'Andrea; I R Marino; M Cervellera; V Tonini
Journal:  Dig Dis Sci       Date:  2019-09       Impact factor: 3.199

2.  Predictors of stent dysfunction after self-expandable metal stent placement for malignant gastric outlet obstruction: tumor ingrowth in uncovered stents and migration of covered stents.

Authors:  Yasuki Hori; Itaru Naitoh; Kazuki Hayashi; Tesshin Ban; Makoto Natsume; Fumihiro Okumura; Takahiro Nakazawa; Hiroki Takada; Atsuyuki Hirano; Naruomi Jinno; Shozo Togawa; Tomoaki Ando; Hiromi Kataoka; Takashi Joh
Journal:  Surg Endosc       Date:  2017-03-09       Impact factor: 4.584

3.  The utility and efficacy of self-expandable metal stents for treating malignant gastric outlet obstructions in patients under best supportive care.

Authors:  Yasuki Hori; Itaru Naitoh; Kazuki Hayashi; Katsuyuki Miyabe; Michihiro Yoshida; Yasuaki Fujita; Makoto Natsume; Naruomi Jinno; Akihisa Kato; Takahiro Nakazawa; Shuya Shimizu; Atsuyuki Hirano; Fumihiro Okumura; Tomoaki Ando; Hitoshi Sano; Hiroki Takada; Shozo Togawa; Takashi Joh
Journal:  Support Care Cancer       Date:  2018-05-03       Impact factor: 3.603

4.  Comparison of uncovered and covered stents for the treatment of malignant duodenal obstruction caused by pancreaticobiliary cancer.

Authors:  Sang Myung Woo; Dong Hwan Kim; Woo Jin Lee; Kyung Woo Park; Sang-Jae Park; Sung-Sik Han; Tae Hyun Kim; Young Hwan Koh; Hyun Bum Kim; Eun Kyung Hong
Journal:  Surg Endosc       Date:  2013-01-04       Impact factor: 4.584

5.  The location of obstruction predicts stent occlusion in malignant gastric outlet obstruction.

Authors:  Douglas Grunwald; Jonah Cohen; Anthony Bartley; Jennifer Sheridan; Ram Chuttani; Mandeep S Sawhney; Douglas K Pleskow; Tyler M Berzin; Meir Mizrahi
Journal:  Therap Adv Gastroenterol       Date:  2016-09-12       Impact factor: 4.409

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.